Major Salivary Gland Carcinoma

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2024-01-18
Clinical Trial Update: Nivolumab and Ipilimumab in Treating Patients With Metastatic/Recurrent ACC of All Sites and Non-ACC Salivary Gland Cancer [Phase 2]
Phase 2 trial evaluating nivolumab and ipilimumab for metastatic/recurrent major and minor salivary gland carcinomas; status/results are not…